These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29516346)

  • 1. Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.
    de Almeida SM; de Pereira AP; Pedroso MLA; Ribeiro CE; Rotta I; Tang B; Umlauf A; Franklin D; Saloner RG; Batista MGR; Letendre S; Heaton RK; Ellis RJ; Cherner M;
    J Neurovirol; 2018 Jun; 24(3):339-349. PubMed ID: 29516346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.
    Miller TR; Weiss JJ; Bräu N; Dieterich DT; Stivala A; Rivera-Mindt M
    J Neurovirol; 2017 Apr; 23(2):260-272. PubMed ID: 27896573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection.
    Sun B; Abadjian L; Rempel H; Monto A; Pulliam L
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):190-6. PubMed ID: 23187938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial.
    Sulkowski M; Hezode C; Gerstoft J; Vierling JM; Mallolas J; Pol S; Kugelmas M; Murillo A; Weis N; Nahass R; Shibolet O; Serfaty L; Bourliere M; DeJesus E; Zuckerman E; Dutko F; Shaughnessy M; Hwang P; Howe AY; Wahl J; Robertson M; Barr E; Haber B
    Lancet; 2015 Mar; 385(9973):1087-97. PubMed ID: 25467560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting-state functional connectivity MRI analysis in Human Immunodeficiency Virus and Hepatitis C Virus co-infected subjects. A pilot study.
    Corgiolu S; Barberini L; Suri JS; Mandas A; Costaggiu D; Piano P; Zaccagna F; Lucatelli P; Balestrieri A; Saba L
    Eur J Radiol; 2018 May; 102():220-227. PubMed ID: 29685540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction.
    Barokar J; McCutchan A; Deutsch R; Tang B; Cherner M; Bharti AR
    J Neurovirol; 2019 Dec; 25(6):792-799. PubMed ID: 31281947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients.
    Zhu JW; Liu FL; Mu D; Deng DY; Zheng YT
    J Med Virol; 2016 Jun; 88(6):987-95. PubMed ID: 26519943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural response to working memory demand predicts neurocognitive deficits in HIV.
    Cohen RA; Siegel S; Gullett JM; Porges E; Woods AJ; Huang H; Zhu Y; Tashima K; Ding MZ
    J Neurovirol; 2018 Jun; 24(3):291-304. PubMed ID: 29280107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
    Puga MAM; Bandeira LM; Pompilio MA; Rezende GR; Soares LS; de Castro VOL; Tanaka TSO; Cesar GA; de Oliveira SMDVL; Teles SA; Yassuda RTS; Weis-Torres SMDS; Basílio SF; Croda J; Motta-Castro ARC
    PLoS One; 2019; 14(8):e0221265. PubMed ID: 31437184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.
    Clifford DB; Vaida F; Kao YT; Franklin DR; Letendre SL; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Grant I; Heaton RK;
    Neurology; 2015 Jan; 84(3):241-50. PubMed ID: 25503616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users.
    Jamalidoust M; Namayandeh M; Moghadami M; Ziyaeyan M
    Virol J; 2017 Jul; 14(1):127. PubMed ID: 28697809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in Nigeria.
    Shenge JA; Odaibo GN; Olaleye DO
    PLoS One; 2019; 14(2):e0210724. PubMed ID: 30726229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.
    Ciccarelli N; Fabbiani M; Grima P; Falasca K; Tana M; Baldonero E; Colafigli M; Silveri MC; Vecchiet J; Cauda R; Di Giambenedetto S
    Infection; 2013 Dec; 41(6):1103-9. PubMed ID: 23839213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV.
    Perry W; Carlson MD; Barakat F; Hilsabeck RC; Schiehser DM; Mathews C; Hassanein TI
    AIDS; 2005 Oct; 19 Suppl 3():S79-84. PubMed ID: 16251832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV.
    Braga EL; Lyra AC; Ney-Oliveira F; Nascimento L; Silva A; Brites C; Marbak R; Lyra LG
    Braz J Infect Dis; 2006 Feb; 10(1):17-21. PubMed ID: 16767310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    Deng H; Deng X; Liu Y; Xu Y; Lan Y; Gao M; Xu M; Gao H; Wu X; Liao B; Chen W; Zhao M; Hu F; Wang Z
    J Med Virol; 2018 Jul; 90(7):1246-1256. PubMed ID: 29574921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection.
    Blackard JT; Komurian-Pradel F; Perret M; Sodoyer M; Smeaton L; St Clair JB; Chapman S; Taylor LE; Paranhos-Baccalà G; Chung RT
    J Med Virol; 2006 Feb; 78(2):202-7. PubMed ID: 16372286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors.
    Alidjinou EK; Moukassa D; Ebatetou-Ataboho E; Mahoungou GH; Pambou JP; Sané F; Prevost B; Bocket L; Ibara JR; Hober D
    J Infect Dev Ctries; 2014 Aug; 8(8):1068-71. PubMed ID: 25116677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.